Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy (2022)
Attributed to:
University of Oxford – Confidence in Concept 2019
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jha2.527
PubMed Identifier: 36051087
Publication URI: http://europepmc.org/abstract/MED/36051087
Type: Journal Article/Review
Parent Publication: eJHaem
Issue: 3
ISSN: 2688-6146